Lv31
260 积分 2022-06-12 加入
Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
5个月前
已完结
Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
5个月前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
5个月前
已完结
PTEN, PIK3CA, p-AKT, and p-p70S6K Status
5个月前
已完结
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy
5个月前
已完结
Mesoporous silica nanoparticles in drug delivery and biomedical applications
6个月前
已完结
Long-circulating doxorubicin and Schizandrin A liposome with drug-resistant liver cancer activity: in vitro and in vivo evaluation
8个月前
已完结
Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin
8个月前
已完结
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
11个月前
已完结
皖公网安备34019202002308
